STAAR Surgical Company (STAA) Stock Forecast, Price Target & Predictions
STAA Stock Forecast
STAAR Surgical Company stock forecast is as follows: an average price target of $54.58 (represents a 118.49% upside from STAA’s last price of $24.98) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.
STAA Price Target
The average price target for STAAR Surgical Company (STAA) is $54.58 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $45.03. This represents a potential 118.49% upside from STAA's last price of $24.98.
STAA Analyst Ratings
According to 13 Wall Street analysts, STAAR Surgical Company's rating consensus is 'Buy'. The analyst rating breakdown for STAA stock is 0 'Strong Buy' (0.00%), 11 'Buy' (84.62%), 1 'Hold' (7.69%), 1 'Sell' (7.69%), and 0 'Strong Sell' (0.00%).
STAAR Surgical Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Ryan Zimmerman | BTIG | $46.00 | $38.07 | 20.83% | 84.15% |
| Apr 09, 2024 | Raj Denhoy | Jefferies | $60.00 | $50.59 | 18.61% | 140.19% |
| Apr 08, 2024 | John Young | Canaccord Genuity | $46.00 | $48.68 | -5.51% | 84.15% |
| Apr 04, 2024 | Margaret Kaczor | William Blair | $45.03 | $45.54 | -1.12% | 80.26% |
| Jan 11, 2023 | Stephens Stephens | Stephens | $85.00 | $68.56 | 23.98% | 240.27% |
| Sep 23, 2022 | Truist Financial | $48.00 | $71.93 | -33.27% | 92.15% | |
| Sep 23, 2022 | RBC Capital | $52.00 | $73.19 | -28.95% | 108.17% | |
| Jul 19, 2022 | Truist Financial | $54.00 | $74.65 | -27.66% | 116.17% | |
| Apr 26, 2022 | Canaccord Genuity | $89.00 | $59.02 | 50.80% | 256.29% | |
| Mar 23, 2022 | Michael Ciarmoli | Truist Financial | $58.00 | $71.96 | -19.40% | 132.19% |
The latest STAAR Surgical Company stock forecast, released on Jun 11, 2024 by Ryan Zimmerman from BTIG, set a price target of $46.00, which represents a 20.83% increase from the stock price at the time of the forecast ($38.07), and a 84.15% increase from STAA last price ($24.98).
STAAR Surgical Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 4 |
| Avg Price Target | - | - | $49.26 |
| Last Closing Price | $24.98 | $24.98 | $24.98 |
| Upside/Downside | -100.00% | -100.00% | 97.20% |
In the current month, the average price target of STAAR Surgical Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to STAAR Surgical Company's last price of $24.98. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 15, 2024 | Morgan Stanley | Underweight | Downgrade | |
| Jun 11, 2024 | Piper Sandler | Buy | Buy | Hold |
| Apr 09, 2024 | Jefferies | Buy | Buy | Hold |
| Apr 08, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Apr 04, 2024 | William Blair | Market Perform | Outperform | Upgrade |
| Apr 04, 2024 | Stifel Nicolaus | Buy | Buy | Hold |
| Mar 11, 2024 | Barclays | Underperform | Underperform | Hold |
| Sep 15, 2023 | Needham | Buy | Buy | Hold |
| Jun 07, 2023 | William Blair | Market Perform | Downgrade | |
| Dec 28, 2022 | Oppenheimer | Outperform | Outperform | Hold |
| Dec 28, 2022 | JMP Securities | Market Outperform | Market Outperform | Hold |
| Dec 28, 2022 | Stephens | Overweight | Overweight | Hold |
| Nov 03, 2022 | Needham | Buy | Buy | Hold |
| Sep 23, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Apr 26, 2022 | Canaccord Genuity | Buy | Buy | Hold |
| Apr 26, 2022 | Benchmark | Buy | Upgrade | |
| Apr 26, 2022 | BTIG | Buy | Buy | Hold |
STAAR Surgical Company's last stock rating was published by Morgan Stanley on Jul 15, 2024. The company Downgrade its STAA rating from "null" to "Underweight".
STAAR Surgical Company Financial Forecast
STAAR Surgical Company Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $76.27K | $80.31M | $92.31M | $73.53M | $64.04M | $76.05M | $81.10M | $63.20M | $59.00M | $58.35M | $62.37M | $50.75M | $38.88M | $47.08M | $35.19M | $35.19M | - | $39.05M |
| Avg Forecast | $137.69M | $131.10M | $124.83M | $118.86M | $87.87M | $99.24M | $110.27M | $84.53M | $77.19M | $86.90M | $95.22M | $75.34M | $75.94M | $80.37M | $92.51M | $66.23M | $64.12M | $74.95M | $80.12M | $60.53M | $59.49M | $57.90M | $52.59M | $44.26M | $44.28M | $42.99M | $35.75M | $32.94M | $38.43M | $38.57M |
| High Forecast | $144.13M | $137.24M | $130.68M | $124.43M | $91.98M | $103.89M | $115.43M | $86.82M | $79.96M | $87.12M | $95.22M | $75.58M | $79.50M | $80.39M | $96.84M | $69.33M | $67.12M | $74.95M | $80.12M | $60.53M | $59.49M | $57.90M | $52.59M | $44.26M | $44.28M | $42.99M | $35.75M | $32.94M | $38.43M | $38.57M |
| Low Forecast | $130.79M | $124.53M | $118.58M | $112.91M | $83.46M | $94.27M | $104.74M | $81.76M | $75.31M | $86.68M | $95.22M | $75.09M | $72.14M | $80.35M | $87.87M | $62.91M | $60.91M | $74.95M | $80.12M | $60.53M | $59.49M | $57.90M | $52.59M | $44.26M | $44.28M | $42.99M | $35.75M | $32.94M | $38.43M | $38.57M |
| # Analysts | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 6 | 8 | 6 | 4 | 4 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.00% | 1.00% | 1.11% | 1.00% | 1.01% | 1.01% | 1.04% | 0.99% | 1.01% | 1.19% | 1.15% | 0.88% | 1.10% | 0.98% | 1.07% | - | 1.01% |
STAAR Surgical Company's average Quarter revenue forecast for Mar 24 based on 4 analysts is $75.34M, with a low forecast of $75.09M, and a high forecast of $75.58M. STAA's average Quarter revenue forecast represents a 98672.49% increase compared to the company's last Quarter revenue of $76.27K (Dec 23).
STAAR Surgical Company EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 6 | 8 | 6 | 4 | 4 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $10.40K | $9.02M | $8.60M | $3.89M | $-847.00K | $16.92M | $19.92M | $14.03M | $7.92M | $8.28M | $11.61M | $7.11M | $3.99M | $6.15M | $164.00K | $-301.00K | - | $4.29M |
| Avg Forecast | $16.58M | $15.79M | $15.04M | $14.32M | $10.58M | $11.95M | $13.28M | $10.18M | $9.30M | $10.47M | $11.47M | $9.07M | $9.15M | $9.68M | $11.14M | $7.98M | $8.75M | $9.21M | $9.84M | $7.44M | $7.31M | $7.11M | $6.46M | $5.44M | $5.44M | $5.28M | $4.39M | $-895.93K | $4.72M | $4.74M |
| High Forecast | $17.36M | $16.53M | $15.74M | $14.99M | $11.08M | $12.51M | $13.90M | $10.46M | $9.63M | $10.49M | $11.47M | $9.10M | $9.58M | $9.68M | $11.66M | $8.35M | $10.50M | $9.21M | $9.84M | $7.44M | $7.31M | $7.11M | $6.46M | $5.44M | $5.44M | $5.28M | $4.39M | $-716.75K | $4.72M | $4.74M |
| Low Forecast | $15.75M | $15.00M | $14.28M | $13.60M | $10.05M | $11.35M | $12.62M | $9.85M | $9.07M | $10.44M | $11.47M | $9.05M | $8.69M | $9.68M | $10.58M | $7.58M | $7.00M | $9.21M | $9.84M | $7.44M | $7.31M | $7.11M | $6.46M | $5.44M | $5.44M | $5.28M | $4.39M | $-1.08M | $4.72M | $4.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.93% | 0.77% | 0.49% | -0.10% | 1.84% | 2.02% | 1.89% | 1.08% | 1.16% | 1.80% | 1.31% | 0.73% | 1.16% | 0.04% | 0.34% | - | 0.91% |
4 analysts predict STAA's average Quarter EBITDA for Mar 24 to be $9.07M, with a high of $9.10M and a low of $9.05M. This is 87111.80% upper than STAAR Surgical Company's previous annual EBITDA (Dec 23) of $10.40K.
STAAR Surgical Company Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 6 | 8 | 6 | 4 | 4 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $7.76K | $4.82M | $6.06M | $2.71M | $6.10M | $10.26M | $13.04M | $9.60M | $4.92M | $6.02M | $8.57M | $4.99M | $6.38M | $3.89M | $-1.17M | $-134.00K | - | $2.39M |
| Avg Forecast | $5.47M | $17.41M | $20.89M | $2.49M | $6.87M | $14.20M | $18.36M | $4.89M | $-1.35M | $8.94M | $11.88M | $82.52M | $8.89M | $8.82M | $14.22M | $75.02M | $5.41M | $9.96M | $11.60M | $68.20M | $8.48M | $8.30M | $4.06M | $53.91M | $4.07M | $4.32M | $374.33K | $-232.22K | $3.49M | $4.61M |
| High Forecast | $5.80M | $18.47M | $22.16M | $2.64M | $7.29M | $15.07M | $19.48M | $6.93M | $2.71M | $9.15M | $11.88M | $99.03M | $14.04M | $9.36M | $15.08M | $90.02M | $6.50M | $9.96M | $11.60M | $81.84M | $8.48M | $8.30M | $4.06M | $64.70M | $4.07M | $4.32M | $374.33K | $-185.77K | $3.49M | $4.61M |
| Low Forecast | $5.11M | $16.27M | $19.53M | $2.32M | $6.43M | $13.28M | $17.17M | $3.26M | $-4.74M | $8.74M | $11.88M | $66.02M | $6.08M | $8.24M | $13.29M | $60.02M | $4.33M | $9.96M | $11.60M | $54.56M | $8.48M | $8.30M | $4.06M | $43.13M | $4.07M | $4.32M | $374.33K | $-278.66K | $3.49M | $4.61M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.55% | 0.43% | 0.04% | 1.13% | 1.03% | 1.12% | 0.14% | 0.58% | 0.73% | 2.11% | 0.09% | 1.57% | 0.90% | -3.13% | 0.58% | - | 0.52% |
STAAR Surgical Company's average Quarter net income forecast for Mar 24 is $82.52M, with a range of $66.02M to $99.03M. STAA's average Quarter net income forecast represents a 1063887.24% increase compared to the company's last Quarter net income of $7.76K (Dec 23).
STAAR Surgical Company SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 6 | 8 | 6 | 4 | 4 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $50.32K | $45.87M | $62.13M | $44.45M | $39.03M | $37.14M | $38.22M | $29.21M | $28.54M | $29.19M | $30.29M | $23.41M | $19.07M | $21.24M | $18.17M | $19.00M | - | $19.56M |
| Avg Forecast | $69.76M | $66.42M | $63.25M | $60.22M | $44.52M | $50.28M | $55.87M | $42.83M | $39.11M | $44.03M | $48.24M | $38.17M | $38.48M | $40.72M | $46.87M | $33.55M | $31.39M | $37.97M | $40.59M | $30.67M | $30.14M | $29.33M | $26.64M | $22.42M | $22.43M | $21.78M | $18.11M | $32.92M | $19.47M | $19.54M |
| High Forecast | $73.03M | $69.53M | $66.21M | $63.04M | $46.60M | $52.64M | $58.48M | $43.99M | $40.51M | $44.14M | $48.24M | $38.29M | $40.28M | $40.73M | $49.06M | $35.12M | $37.67M | $37.97M | $40.59M | $30.67M | $30.14M | $29.33M | $26.64M | $22.42M | $22.43M | $21.78M | $18.11M | $39.51M | $19.47M | $19.54M |
| Low Forecast | $66.26M | $63.09M | $60.08M | $57.20M | $42.29M | $47.76M | $53.07M | $41.42M | $38.16M | $43.92M | $48.24M | $38.05M | $36.55M | $40.71M | $44.52M | $31.87M | $25.11M | $37.97M | $40.59M | $30.67M | $30.14M | $29.33M | $26.64M | $22.42M | $22.43M | $21.78M | $18.11M | $26.34M | $19.47M | $19.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.13% | 1.33% | 1.32% | 1.24% | 0.98% | 0.94% | 0.95% | 0.95% | 1.00% | 1.14% | 1.04% | 0.85% | 0.98% | 1.00% | 0.58% | - | 1.00% |
STAAR Surgical Company's average Quarter SG&A projection for Mar 24 is $38.17M, based on 4 Wall Street analysts, with a range of $38.05M to $38.29M. The forecast indicates a 75753.03% rise compared to STAA last annual SG&A of $50.32K (Dec 23).
STAAR Surgical Company EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 6 | 8 | 6 | 4 | 4 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.16 | $0.10 | $0.13 | $0.06 | $0.13 | $0.21 | $0.27 | $0.20 | $0.10 | $0.13 | $0.18 | $0.11 | $0.14 | $0.08 | $-0.03 | $-0.00 | - | $0.05 |
| Avg Forecast | $0.11 | $0.35 | $0.42 | $0.05 | $0.14 | $0.29 | $0.37 | $0.10 | $-0.03 | $0.18 | $0.24 | $0.06 | $0.18 | $0.18 | $0.29 | $0.07 | $0.13 | $0.20 | $0.23 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 |
| High Forecast | $0.12 | $0.37 | $0.45 | $0.05 | $0.15 | $0.30 | $0.39 | $0.14 | $0.05 | $0.18 | $0.24 | $0.06 | $0.28 | $0.19 | $0.30 | $0.08 | $0.14 | $0.20 | $0.23 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 |
| Low Forecast | $0.10 | $0.33 | $0.39 | $0.05 | $0.13 | $0.27 | $0.35 | $0.07 | $-0.10 | $0.18 | $0.24 | $0.06 | $0.12 | $0.17 | $0.27 | $0.07 | $0.13 | $0.20 | $0.23 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.56% | 0.45% | 0.81% | 0.96% | 1.05% | 1.16% | 1.33% | 0.59% | 0.78% | 2.21% | 3.30% | 1.71% | 0.92% | -3.99% | -0.11% | - | 0.54% |
According to 4 Wall Street analysts, STAAR Surgical Company's projected average Quarter EPS for Mar 24 is $0.06, with a low estimate of $0.06 and a high estimate of $0.06. This represents a -61.72% decrease compared to STAA previous annual EPS of $0.16 (Dec 23).
STAAR Surgical Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| STAA | STAAR Surgical Company | $25.44 | $54.58 | 114.54% | Buy |
| ANGO | AngioDynamics | $9.26 | $13.00 | 40.39% | Buy |
| HAE | Haemonetics | $82.07 | $107.00 | 30.38% | Buy |
| BDX | Becton, Dickinson and Company | $225.64 | $278.75 | 23.54% | Buy |
| ATR | AptarGroup | $163.09 | $200.00 | 22.63% | Buy |
| RGEN | Repligen | $158.14 | $193.40 | 22.30% | Buy |
| COO | Cooper Companies | $94.49 | $115.00 | 21.71% | Buy |
| ICUI | ICU Medical | $157.17 | $190.50 | 21.21% | Buy |
| WST | West Pharmaceutical Services | $334.26 | $393.00 | 17.57% | Buy |
| MMSI | Merit Medical Systems | $99.00 | $108.83 | 9.93% | Buy |
| NVST | Envista | $19.24 | $20.29 | 5.46% | Hold |
| HOLX | Hologic | $72.26 | $74.20 | 2.68% | Buy |
| RMD | ResMed | $242.62 | $233.50 | -3.76% | Hold |